Dr. Passik | BOD for IHFDA
Millennium Health VP, Scientific Affairs & Head of Clinical Data Programs Steven Passik, PhD Appointed to Board of Directors for International Health Facility Diversion Association
SAN DIEGO, Calif. – March 29, 2022 – The International Health Facility Diversion Association (IHFDA) has tapped the expertise of Millennium Health’s Vice President, Scientific Affairs & Head of Clinical Data Programs Steven Passik, PhD for its Board of Directors.
IHFDA’s mission is devoted to protecting patients, staff, and facilities from the harm associated with drug diversion by healthcare personnel through education and collaboration. Dr. Passik’s significant experience in working with cancer and non-cancer pain patients and their families, in addition to his consummate knowledge about the interface of pain and addiction will provide valuable insight and guidance for the organization and its mission.
“We are so pleased to have Dr. Passik join our Board and look forward to collaborating with him as we continue to seek out ways to help prevent drug diversion in the healthcare industry”, says John Burke, IHFDA Executive Director. “Additionally, his access to important drug use trends data through the Millennium Health Emerging Threat Program will allow us to better understand how the changing landscape of substance use in our country is impacting the industry as a whole.”
About Millennium Health
Millennium Health is an accredited specialty laboratory providing medication monitoring via definitive urine and oral fluid drug tests to support improved clinical decision-making as part of treatment for millions of Americans with chronic pain, mental illness, substance use disorders, and other health conditions. Drug testing is used to obtain objective information about patients’ recent use of prescription medications and/or illicit drugs and helps monitor the effectiveness of treatment plans. We also conduct real-time tracking of emerging drug use trends to help researchers, public health officials, and policymakers address the significant increase in drug overdose deaths.